Invus Global Management, LLC, Director, 10% Owner at LEXICON PHARMACEUTICALS, INC. (LXRX), bought 1,538,462 shares at $1.30 ($2.0M) on 2026-02-02, disclosed to the SEC on 2026-02-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.